Powered by semiconductor biochip technology, the platform integrates chemical surface modification and A.I. image interpretation to capture and analyze cancer cells from blood samples. It delivers true cell level liquid biopsy and enables an automated system for cancer cell identification.

▸ The semiconductor biochip features a dual mechanism design, nanopillar structures and chemical surface modification, for highly efficient and specific cancer cell capture.

▸ Automated immunofluorescence staining allows simultaneous labeling of multiple cancer antigens, facilitating cell classification and cancer subtyping.

▸ From sample loading and cell capture to staining and AI interpretation, the entire workflow is fully automated to ensure consistency and scalability.